Company profile: Adverum Biotechnologies
1.1 - Company Overview
Company description
- Provider of gene therapy, developing medicines with therapeutic benefits. Offerings include Ixo-vec, a gene therapy product candidate for wet age-related macular degeneration designed for single administration, and the OPTIC clinical program investigating the safety, efficacy, and long-term outcomes of Ixo-vec in wet AMD patients.
Products and services
- Gene Therapy Medicines Development: Gene-therapy-focused program that develops medicines intended to offer therapeutic benefits to patients, emphasizing creation of therapeutic products
- Ixo-vec: Investigational gene therapy for wet age-related macular degeneration, designed for single administration to deliver therapeutic benefits to patients as a one-time treatment
- OPTIC Clinical Program: Long-term clinical program investigating Ixo-vec’s safety and efficacy in wet AMD patients, assessing long-term outcomes to characterize treatment performance
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Adverum Biotechnologies
MoBiTec
HQ: Germany
Website
- Description: Provider of research tools for life science, diagnostic, and pharmaceutical companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MoBiTec company profile →
Applied DNA Sciences
HQ: United States
Website
- Description: Provider of botanical DNA-based anti-counterfeiting, product authentication, and genetic testing solutions, offering Linea DNA for rapid, cell-free production of high-fidelity DNA for nucleic acid therapies; CertainT and SigNature DNA for supply chain source and authenticity verification; ADCL PCR-based virology testing; and TR8 pharmacogenomic testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Applied DNA Sciences company profile →
DNA Script
HQ: France
Website
- Description: Provider of enzymatic DNA synthesis solutions, featuring the SYNTAX benchtop DNA printer for on-demand custom oligo production up to 120 nucleotides using Enzymatic DNA Synthesis (EDS). Offers SYNTAX 96 Hi-Fidelity and 96 Standard kits for 96 oligos (up to 120 nt or 80 nt), the SYNTAX 192 Label Kit for probes with up to two labels for qPCR and FISH, and SYNTAX Labels including fluorophores, quenchers, and biotin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DNA Script company profile →
GenoSpace
HQ: United States
Website
- Description: Provider of a precision medicine software platform that makes biomedical data useful and usable, enabling interpretation, analysis, reporting, and collaboration. Offers clinical trial matching using clinical-genomic data, EMR-to-EDC integration to transfer EMR data to clinical trial databases, and study feasibility and site selection tools evaluating enrollment potential and competing trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenoSpace company profile →
Verve Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage genetic medicines for cardiovascular disease, including gene editing therapies VERVE-101 targeting PCSK9 to lower LDL-C in heterozygous familial hypercholesterolemia and ASCVD, and VERVE-201 targeting ANGPTL3 for homozygous and refractory hypercholesterolemia, enabled by a proprietary GalNAc-LNP liver delivery system, with medicines evaluated in clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verve Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Adverum Biotechnologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Adverum Biotechnologies
2.2 - Growth funds investing in similar companies to Adverum Biotechnologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Adverum Biotechnologies
4.2 - Public trading comparable groups for Adverum Biotechnologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →